Nektar Therapeutics (NKTR)
70.70
-1.75
(-2.42%)
USD |
NASDAQ |
Mar 06, 16:00
70.59
-0.11
(-0.16%)
After-Hours: 20:00
Nektar Therapeutics SG&A Expense (TTM) : 74.62M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Rigel Pharmaceuticals, Inc. | 85.91M |
| Insmed, Inc. | 701.17M |
| Regeneron Pharmaceuticals, Inc. | 2.70B |
| Ironwood Pharmaceuticals, Inc. | 82.26M |
| Lyell Immunopharma, Inc. | 49.04M |